Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.99B |
| 2 |
Apple
AAPL
|
+$2.23B |
| 3 |
NVIDIA
NVDA
|
+$1.92B |
| 4 |
Amazon
AMZN
|
+$1.75B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altair Engineering Inc
ALTR
|
+$152M |
| 2 |
Merck
MRK
|
+$142M |
| 3 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$141M |
| 4 |
ALTM
Arcadium Lithium plc
ALTM
|
+$132M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.36% |
| 2 | Financials | 14.54% |
| 3 | Healthcare | 11.04% |
| 4 | Consumer Discretionary | 10.44% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
Apyx Medical
APYX
$171M
| $491K | ﹤0.01% |
358,151
+5,342
| +2% | +$7.36K |
|
|
IGMS
3552
DELISTED
IGM Biosciences
IGMS
| $490K | ﹤0.01% |
425,660
+16,527
| +4% | +$30.7K |
|
3553
OPAL Fuels
OPAL
$70.7M
| $489K | ﹤0.01% |
265,895
+3,019
| +1% | +$8.26K |
|
3554
Century Casinos
CNTY
$34M
| $489K | ﹤0.01% |
289,455
+3,622
| +1% | +$9.84K |
|
3555
Rafael Holdings
RFL
$107M
| $488K | ﹤0.01% |
264,613
+87,608
| +49% | +$170K |
|
3556
Alpha Pro Tech
APT
$53.1M
| $487K | ﹤0.01% |
97,411
+722
| +0.7% | +$3.86K |
|
|
IMDX
3557
Insight Molecular Diagnostics
IMDX
$156M
| $486K | ﹤0.01% |
158,907
+21,838
| +16% | +$59K |
|
3558
ALX Oncology
ALXO
$290M
| $480K | ﹤0.01% |
770,907
+30,801
| +4% | +$37K |
|
|
SA
3559
Seabridge Gold
SA
$3.35B
| $480K | ﹤0.01% |
40,704
+3,055
| +8% | +$36.2K |
|
3560
Microbot Medical
MBOT
$127M
| $479K | ﹤0.01% |
316,918
+174,259
| +122% | +$308K |
|
3561
Elicio Therapeutics
ELTX
$83.8M
| $477K | ﹤0.01% |
77,467
+6,746
| +10% | +$52.3K |
|
3562
Cineverse
CNVS
$65.6M
| $473K | ﹤0.01% |
149,615
+9,899
| +7% | +$37.1K |
|
3563
Sportsman's Warehouse
SPWH
$46M
| $471K | ﹤0.01% |
473,246
+40,136
| +9% | +$67.6K |
|
3564
PMV Pharmaceuticals
PMVP
$63.5M
| $470K | ﹤0.01% |
430,792
+9,082
| +2% | +$12.3K |
|
|
SUP
3565
DELISTED
Superior Industries International
SUP
| $469K | ﹤0.01% |
220,262
+590
| +0.3% | +$1.21K |
|
3566
Natural Health Trends
NHTC
$14.8M
| $469K | ﹤0.01% |
92,724
+5,339
| +6% | +$26.5K |
|
3567
Grupo Aeroportuario del Pacifico
PAC
$13.3B
| $469K | ﹤0.01% |
2,529
-86
| -3% | -$16.3K |
|
3568
Forte Biosciences
FBRX
$1.57B
| $466K | ﹤0.01% |
60,082
+43,205
| +256% | +$510K |
|
|
CIRC
3569
Circle8 Group
CIRC
$65.1M
| $465K | ﹤0.01% |
+115,505
| New | +$497K |
|
3570
Century Therapeutics
IPSC
$361M
| $462K | ﹤0.01% |
970,260
-21,335
| -2% | -$16K |
|
3571
One Stop Systems
OSS
$330M
| $459K | ﹤0.01% |
197,892
+7,675
| +4% | +$25.7K |
|
3572
Katapult Holdings
KPLT
$33.2M
| $457K | ﹤0.01% |
44,661
+4,707
| +12% | +$47K |
|
3573
MarketWise
MKTW
$56.6M
| $456K | ﹤0.01% |
46,216
+4,139
| +10% | +$49.5K |
|
3574
Catalyst Bancorp
CLST
$70M
| $456K | ﹤0.01% |
39,144
+680
| +2% | +$7.94K |
|
3575
Assembly Biosciences
ASMB
$529M
| $456K | ﹤0.01% |
47,703
+1,068
| +2% | +$14K |
|
Similar funds
Geode Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Geode Capital Management held 4,591 positions worth $1.27T, down 1.4% from $1.29T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Geode Capital Management deployed $47.9B of net new capital in Q1 2025, opening 122 new positions and adding to 3,780 existing holdings. Its largest new stake was Sandisk: 1,936,245 shares worth $92.2M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Merck, an estimated $142M trimmed.
- Geode Capital Management's largest Q1 2025 buy was Sandisk: 1,936,245 shares worth $92.2M.
- Geode Capital Management added most to Microsoft in Q1 2025, an estimated $2.99B increase.
- Geode Capital Management's biggest Q1 2025 reduction was Merck, cutting an estimated $142M.
- Geode Capital Management fully exited Altair Engineering Inc in Q1 2025, selling an estimated $152M.
- Geode Capital Management's ten largest holdings make up 29% of its $1.27T portfolio in Q1 2025.
- Geode Capital Management opened 122 new positions and closed 115 in Q1 2025.
- Geode Capital Management's portfolio value fell 1.4% quarter-over-quarter to $1.27T.
Based on Geode Capital Management's 13F filing for Q1 2025, filed 13 May 2025.